Pharmaceutical Manufacturing Decline in Tanzania: How Possible Is a Turnaround to Growth?

  • Paula Tibandebage
  • Samuel Wangwe
  • Maureen Mackintosh
  • Phares G. M. Mujinja
Part of the International Political Economy Series book series (IPES)

Abstract

As Chapter 1 described, Tanzania has a decades-long history of pharmaceutical production, the sector mirroring fluctuations in Tanzania’s post-independence industrial history. By 2004–05, the sector was estimated to be producing pharmaceuticals worth US$32.5 million, supplying around 30% of the local market and exporting about 10% of local production (MoHSW, 2006). The subsequent rise and decline of the sector is analysed in this chapter, locating firms’ sources of both market resilience and vulnerability in local patterns of ownership, finance and management, interacting with the internationalization of firms’ domestic and regional markets. Finally, the chapter examines the ‘turnaround’ challenge facing the local industry. Concerned policy makers are aware, as the above quotation shows, of the health sector insecurity inherent in complete reliance on medicines imports.

Keywords

Tuberculosis Penicillin Marketing Folic Acid Malaria 

Copyright information

© Paula Tibandebage, Samuel Wangwe, Maureen Mackintosh and Phares G.M. Mujinja 2016

Open Access This Chapter is distributed under the terms of the Creative Commons Attribution Noncommercial License, which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Authors and Affiliations

  • Paula Tibandebage
  • Samuel Wangwe
  • Maureen Mackintosh
  • Phares G. M. Mujinja

There are no affiliations available

Personalised recommendations